423-637-6991 [email protected]

Center for Precision Medicine

Director- Thomas Devlin MD, PhD
Research and Lab Directors- Elizabeth Forrester, PhD, Dawn Richards, PhD, Jeffrey Merrill, PharmD

According to the Precision Medicine Initiative, precision medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Affiliated scientists and physicians at The NeuroScience Innovation Foundation Center for Precision Medicine identify and investigate opportunities for Precision Medicine and develop testing assays with industry partners at Athena Esoterix in Chattanooga, TN.

NSIF_ Precision Medicine
NSIF_ Center for Alzheimer’s

Center for Alzheimer’s- Immune System Nexus

Director: Thomas Devlin MD, PhD (interim)
Center for Alzheimer’s- Immune System Nexus is devoted to the investigation of medical therapies to halt and reverse Alzheimer’s Disease (AD) based on novel theories on a Brain- Immune System Nexus especially advances developed by Michal Schwartz, PhD of the Weizmann Institute in Israel. The AD- Immune system Nexus understands various neurological disorders, including AD, Parkinson’s and head trauma as the result of genetic disorders which block the access of the immune system to injured sites in the brain. Locking out the immune system from access to the brain results in the accumulation of insults and injuries to brain tissue that are normally mitigated by specialized scavenger and repair functions of the immune system. Genetic based medical therapies have been developed to eradicate symptoms of various neurological disorders including Alzheimer’s Disease in “humanized” animal models. These medicines are already in human trials outside the US. The Foundation intends to facilitate research ties to institutions engaged in this novel approach to AD and will also organize seminars among relevant medical and scientific professionals to further explore the Brain- Immune System Nexus.

Developing Tomorrow’s Medical Breakthrough Technologies Today

423-637-6991

725 Glenwood Drive,
Rm 880-A
Chattanooga, TN 37404

© NeuroScience Innovation Foundation 2023

web design by Mark Devlin Visual Design  www.md-visualdesign.com